rts logo

Exact Sciences Corp. (EXAS) – key numbers that make it a Strong Buy For Now

Exact Sciences Corp. (NASDAQ: EXAS) is -0.32% lower on its value in year-to-date trading and has touched a low of $56.05 and a high of $100.77 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EXAS stock was last observed hovering at around $70.41 in the last trading session, with the day’s gains setting it 3.33%.

Currently trading at $73.74, the stock is 19.22% and 18.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.35 million and changing 4.73% at the moment leaves the stock 1.53% off its SMA200. EXAS registered 11.29% gain for a year compared to 6-month loss of 8.09%. The firm has a 50-day simple moving average (SMA 50) of $6.07 and a 200-day simple moving average (SMA200) of $517.81.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a 24.06% gain in the last 1 month and extending the period to 3 months gives it a -0.32%, and is 15.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.29% over the week and 4.70% over the month.

Exact Sciences Corp. (EXAS) has around 6600 employees, a market worth around $13.39B and $2.50B in sales. Fwd P/E is 593.91. Profit margin for the company is -8.17%. Distance from 52-week low is 31.56% and -26.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.63%).

Exact Sciences Corp. quarterly earnings per share for the current quarter are estimated at -$0.46 with sales reaching $628.92M over the same period.The EPS is expected to grow by 21.81% this year, but quarterly earnings will post 13.30% year-over-year. Quarterly sales are estimated to grow 4.40% in year-over-year returns.

Exact Sciences Corp. (EXAS) Top Institutional Holders

918 institutions hold shares in Exact Sciences Corp. (EXAS), with institutional investors hold 90.43% of the company’s shares. The shares outstanding are 181.36M, and float is at 179.64M with Short Float at 3.63%. Institutions hold 89.51% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 17.56 million shares valued at $1.65 billion. The investor’s holdings represent 9.72% of the EXAS Shares outstanding. As of Jun 29, 2023, the second largest holder is JP Morgan Chase & Company with 15.0 million shares valued at $1.41 billion to account for 8.30% of the shares outstanding. The other top investors are Blackrock Inc. which holds 11.17 million shares representing 6.18% and valued at over $1.05 billion, while Wellington Management Group, LLP holds 5.98% of the shares totaling 10.8 million with a market value of $1.01 billion.

Exact Sciences Corp. (EXAS) Insider Activity

The most recent transaction is an insider sale by Condella Sarah,the company’sEVP, Human Resources. SEC filings show that Condella Sarah sold 2,000 shares of the company’s common stock on Mar 28 ’24 at a price of $70.00 per share for a total of $0.14 million. Following the sale, the insider now owns 73787.0 shares.

Exact Sciences Corp. disclosed in a document filed with the SEC on Mar 01 ’24 that Conroy Kevin T (President and CEO) sold a total of 8,271 shares of the company’s common stock. The trade occurred on Mar 01 ’24 and was made at $59.32 per share for $0.49 million. Following the transaction, the insider now directly holds 1.3 million shares of the EXAS stock.

Still, SEC filings show that on Mar 01 ’24, LEVANGIE DANIEL J (Director) disposed off 5,000 shares at an average price of $57.50 for $0.29 million. The insider now directly holds 22,975 shares of Exact Sciences Corp. (EXAS).

Related Posts